articleThe Lancet NeurologyOct 22, 2010Closed access

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

University of California, San Francisco · Cancer Research And Biostatistics · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

677
total citations
FWCI
35.24
Percentile
100%
References
39
Citations per year

Authors

26

Topics & keywords

Keywords
  • Neurturin
  • Medicine
  • Clinical endpoint
  • Consolidated Standards of Reporting Trials
  • Adverse effect
  • Randomized controlled trial
  • Clinical trial
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding